Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2021 from OUS - Division of Cancer Medicine

11 publications found

Bong WK, Gaustadnes LM, Bergland A, Chen W, Bye A (2021)
Community-living older people's interpretation of the Norwegian version of older people's quality of life (OPQOL) questionnaire
Health Soc Care Community (in press)
DOI 10.1111/hsc.13273, PubMed 33440057

Cunha ES, Chen X, Sanz-Gaitero M, Mills DJ, Luecke H (2021)
Cryo-EM structure of Helicobacter pylori urease with an inhibitor in the active site at 2.0 Å resolution
Nat Commun, 12 (1), 230
DOI 10.1107/S0907444904019158, PubMed 33431861

Engeseth M, Enden T, Sandset PM, Wik HS (2021)
Predictors of long-term post-thrombotic syndrome following high proximal deep vein thrombosis: a cross-sectional study
Thromb J, 19 (1), 3
DOI 10.1186/s12959-020-00253-8, PubMed 33419441

Galili B, Tekpli X, Kristensen VN, Yakhini Z (2021)
Efficient gene expression signature for a breast cancer immuno-subtype
PLoS One, 16 (1), e0245215
DOI 10.1371/journal.pone.0245215, PubMed 33434192

Hustad KS, Ottestad I, Hjorth M, Dalen KT, Sæther T, Sheikh NA, Strømnes M, Ulven SM, Holven KB (2021)
No effect of salmon fish protein on 2h-glucose in adults with increased risk of type 2 diabetes: a randomised controlled trial
Br J Nutr, 1-32 (in press)
DOI 10.1017/S0007114521000040, PubMed 33413727

Lilleheie I, Debesay J, Bye A, Bergland A (2021)
The tension between carrying a burden and feeling like a burden: a qualitative study of informal caregivers' and care recipients' experiences after patient discharge from hospital
Int J Qual Stud Health Well-being, 16 (1), 1855751
DOI 10.1080/17482631.2020.1855751, PubMed 33345749

Liposits G, Orrevall Y, Kaasa S, Österlund P, Cederholm T (2021)
Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on Clinical Practice
JCO Oncol Pract, OP2000704 (in press)
DOI 10.1200/OP.20.00704, PubMed 33444111

Liu MS, Zhao H, Xu CX, Xie PB, Wang W, Yang YY, Lee WH, Jin Y, Zhou HQ (2021)
Clinical significance of EPHX2 deregulation in prostate cancer
Asian J Androl, 23 (1), 109-115
DOI 10.4103/aja.aja_34_20, PubMed 32687069

Ngari MM, Obiero C, Mwangome MK, Nyaguara A, Mturi N, Murunga S, Otiende M, Iversen PO, Fegan GW, Walson JL, Berkley JA (2021)
Mortality during and following hospital admission among school-aged children: a cohort study
Wellcome Open Res, 5, 234
DOI 10.12688/wellcomeopenres.16323.2, PubMed 33195820

Panagopoulos I, Andersen K, Eilert-Olsen M, Zeller B, Munthe-Kaas MC, Buechner J, Osnes LTN, Micci F, Heim S (2021)
Therapy-induced Deletion in 11q23 Leading to Fusion of KMT2A With ARHGEF12 and Development of B Lineage Acute Lymphoplastic Leukemia in a Child Treated for Acute Myeloid Leukemia Caused by t(9;11)(p21;q23)/KMT2A-MLLT3
Cancer Genomics Proteomics, 18 (1), 67-81
DOI 10.21873/cgp.20242, PubMed 33419897

Stjepanovic N, Lubinski J, Moller P, Randall Armel S, Foulkes WD, Tung N, Neuhausen SL, Kotsopoulos J, Sun P, Sun S, Eisen A, Narod SA, Hereditary Breast Cancer Clinical Study Group (2021)
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers
Breast Cancer Res Treat (in press)
DOI 10.1016/j.ejca.2020.03.009, PubMed 33423179

 
Page visits: 516803